Compass Therapeutics, Inc.
CMPX
$1.78
$0.031.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -49.38M | -47.76M | -47.24M | -45.44M | -42.49M |
| Total Depreciation and Amortization | 1.75M | 1.86M | 1.86M | 1.87M | 1.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.91M | 5.73M | 4.65M | 3.85M | 2.89M |
| Change in Net Operating Assets | -4.14M | -7.88M | -2.19M | -2.55M | -2.91M |
| Cash from Operations | -44.86M | -48.05M | -42.92M | -42.28M | -40.62M |
| Capital Expenditure | -44.00K | -53.00K | -19.00K | -30.00K | -30.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.82M | 37.77M | 25.77M | 18.63M | 27.00M |
| Cash from Investing | 46.77M | 37.72M | 25.75M | 18.60M | 26.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.11M | 18.11M | 18.13M | 21.26M | 3.19M |
| Repurchase of Common Stock | -232.00K | -295.00K | -295.00K | -295.00K | -159.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -543.00K | -544.00K | -542.00K | -638.00K | -94.00K |
| Cash from Financing | 17.34M | 17.27M | 17.30M | 20.33M | 2.94M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.26M | 6.94M | 126.00K | -3.35M | -10.72M |